NF-κB downregulates BACE1 to reduce Aβ, inflammatory factors including TNF-α, IL-6, IL-12, and tau phosphorylation via Cdk5/P25, which could be abnormally activated in AD. Here, IL6 is linked to Alzheimer disease.